Poland· PL-100374039

Microlax

A natriumlaurylsulfoacetat, inkl. kombinationen product containing sorbitolum liquidum cristallisabile + natrii laurilsulfoacetas + natrii citras, registered in Poland by McNeil AB. The same ATC class is registered in 9 of our 19 countries.

ATC A06AG11

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMicrolaxATCA06AG11REGISTER NO.PL-100374039PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Natriumlaurylsulfoacetat, inkl. kombinationen is registered in 9 of 19 countries.

Countries holding a registration under ATC A06AG11 (natriumlaurylsulfoacetat, inkl. kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Natriumlaurylsulfoacetat, inkl. kombinationen · ATC A06AG11

9 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Sorbitolum liquidum cristallisabile + Natrii laurilsulfoacetas + Natrii citras
Manufacturer
McNeil AB
Country
Poland (PL)
ATC code
A06AG11
ATC class
Natriumlaurylsulfoacetat, inkl. Kombinationen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991363925
  • gtin
    05909991363932
  • gtin
    05909991363949
  • gtin
    03574661429403

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ea052db0-eeca-4154-899d-503a8d8f0e2d
GET /v1/drugs/ea052db0-eeca-4154-899d-503a8d8f0e2d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór doodbytniczy",
  "source": "urpl",
  "strength": "4,465 g + 0,0645 g + 0,45 g",
  "packaging": "05909991363925 ¦ OTC ¦ 126921\n6 poj. 5 ml\n05909991363932 ¦ OTC ¦ 126922\n12 poj. 5 ml\n05909991363949 ¦ OTC ¦ 126923\n50 poj. 5 ml\n03574661429403 ¦ OTC ¦ 126934\n4 poj. 5 ml",
  "substance": "Sorbitolum liquidum cristallisabile 450 mg + Natrii laurilsulfoacetas 64.5 mg + Natrii citras 4465 mg",
  "common_name": "Sorbitolum liquidum cristallisabile + Natrii laurilsulfoacetas + Natrii citras",
  "pl_product_id": "100374039",
  "pozwolenie_nr": "24583",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about natriumlaurylsulfoacetat, inkl. kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.